242 related articles for article (PubMed ID: 19416255)
1. Juvenile onset of primary low-grade cutaneous B-cell lymphoma.
Amitay-Laish I; Feinmesser M; Ben-Amitai D; David M; Manor Y; Kidron D; Barzilai A; Hodak E
Br J Dermatol; 2009 Jul; 161(1):140-7. PubMed ID: 19416255
[TBL] [Abstract][Full Text] [Related]
2. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.
Bergman R; Kurtin PJ; Gibson LE; Hull PR; Kimlinger TK; Schroeter AL
Arch Dermatol; 2001 Apr; 137(4):432-9. PubMed ID: 11295923
[TBL] [Abstract][Full Text] [Related]
4. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
5. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
6. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
9. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
11. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
12. Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
Brown HA; Gibson LE; Pujol RM; Lust JA; Pittelkow MR
J Am Acad Dermatol; 2002 Dec; 47(6):856-62. PubMed ID: 12451369
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphoma in a child.
Condarco T; Sagatys E; Prakash AV; Rezania D; Cualing H
Fetal Pediatr Pathol; 2008; 27(4-5):206-14. PubMed ID: 18800263
[TBL] [Abstract][Full Text] [Related]
14. Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas.
Burg G; Schmid MH; Küng E; Dommann S; Dummer R
Dermatol Clin; 1994 Apr; 12(2):399-407. PubMed ID: 8045051
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases.
Hoefnagel JJ; Vermeer MH; Jansen PM; Heule F; van Voorst Vader PC; Sanders CJ; Gerritsen MJ; Geerts ML; Meijer CJ; Noordijk EM; Willemze R
Arch Dermatol; 2005 Sep; 141(9):1139-45. PubMed ID: 16172311
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous B cell processes with nodular pattern].
Chirife AM; Bilbao ER; Giménez L; Marino L
Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
18. Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.
Morales AV; Advani R; Horwitz SM; Riaz N; Reddy S; Hoppe RT; Kim YH
J Am Acad Dermatol; 2008 Dec; 59(6):953-7. PubMed ID: 18817999
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
[TBL] [Abstract][Full Text] [Related]
20. Two pediatric cases of primary cutaneous B-cell lymphoma and review of the literature.
Sharon V; Mecca PS; Steinherz PG; Trippett TM; Myskowski PL
Pediatr Dermatol; 2009; 26(1):34-9. PubMed ID: 19250402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
